Because CellCept has been associated with an increased incidence of digestive system adverse events, including infrequent cases of gastrointestinal tract ulceration, haemorrhage and perforation, CellCept should be administered with caution in patients with active serious digestive system disease.
Por este motivo CellCept debe administrarse con precaución en pacientes con enfermedad activa grave del aparato digestivo.